# Acthar in Treatment of Refractory Dermatomyositis and Polymyositis

> **NCT01906372** · PHASE2 · COMPLETED · sponsor: **Rohit Aggarwal, MD** · enrollment: 12 (actual)

## Conditions studied

- Dermatomyositis
- Polymyositis

## Interventions

- **DRUG:** Adrenocorticotropic Hormone Gel

## Key facts

- **NCT ID:** NCT01906372
- **Lead sponsor:** Rohit Aggarwal, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-09
- **Final completion:** 2016-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01906372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01906372, "Acthar in Treatment of Refractory Dermatomyositis and Polymyositis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01906372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*